AstraZeneca and the University of Manchester announced that they have entered into a strategic biotech partnership to develop cutting-edge drug delivery technologies.
The five-year collaboration will also build a new manufacturing laboratory to be called the North West Centre for Advanced Drug Delivery.
The lab will be located in Manchester Pharmacy School and run under the joint leadership of the University’s Professor Nicola Tirelli and AstraZeneca's Dr. Marcel de Matas.
The North West Centre will aim to advance basic understanding of drug delivery systems including aspects of biology and physiology.
These new delivery systems will center on crucial therapeutic areas for AstraZeneca, such as cancer.
AstraZeneca scientists will be completely engaged in research projects and will also teach fundamentals of academic courses in Manchester.
University’s researchers will be given the chance to apply their scientific ideas in AstraZeneca’s drug development programs.
For further deal information visit Current Agreements (subscription required)
Report: Top 50 Big Biotech Partnering and M&A Deal Trends
View: Partnering Scorecard in CP Insight– view top life science partnering deals by value
View: DealMetrics in CP Insight – the latest deal trend infographics for life science deal making
View: CP Insight’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: CP Insight’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity